PAI-1 and the Risk of Cardiovascular Disease
作者： Irène Juhan-Vague , Marie Christine Alessi
DOI: 10.1007/978-94-011-5022-4_10
关键词: Internal medicine 、 Coronary risk factors 、 Risk factor 、 Framingham Risk Score 、 Medicine 、 Disease 、 Plasminogen activator 、 Cardiology
摘要: Among the list of coronary risk factors, it has recently been proposed that impairment fibrinolytic system detected in plasma, due to increased plasminogen activator inhibitor -1 (PAI-1) level, could predict complications atherosclerosis.
springer.com
sci-hub.st 参考文章(72)
F Haverkate, S G Thompson, F Duckert, Haemostasis Factors in Angina Pectoris; Relation to Gender, Age and Acute-phase Reaction Thrombosis and Haemostasis. ,vol. 73, pp. 561- 567 ,(1995) , 10.1055/S-0038-1653821
Ducimetière P, Richard Jl, Eschwege E, Rosselin Ge, Warnet Jm, Thibult N, Claude, Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Hormone and metabolic research. Supplement series. ,vol. 15, pp. 41- 46 ,(1985)
Ph Vague, I Juhan-Vague, M C Alessi, C Badier, J Valadier, Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. Thrombosis and Haemostasis. ,vol. 57, pp. 326- 328 ,(1987) , 10.1055/S-0038-1651126
S.J. Dawson, B. Wiman, A. Hamsten, F. Green, S. Humphries, A.M. Henney, The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. Journal of Biological Chemistry. ,vol. 268, pp. 10739- 10745 ,(1993) , 10.1016/S0021-9258(18)82047-6
Leo P. Krall, K. G. M. M. Alberti, The Diabetes annual Elsevier Science Publishers B.V.. ,(1985)
F. Samad, D. J. Loskutoff, Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Molecular Medicine. ,vol. 2, pp. 568- 582 ,(1996) , 10.1007/BF03401641
D Collen, HR Lijnen, Basic and Clinical Aspects of Fibrinolysis and Thrombolysis Blood. ,vol. 78, pp. 3114- 3124 ,(1991) , 10.1182/BLOOD.V78.12.3114.3114
Simon G. Thompson, Joachim Kienast, Stephen D.M. Pyke, Frits Haverkate, Jürgen C.W. van de Loo, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. The New England Journal of Medicine. ,vol. 332, pp. 635- 641 ,(1995) , 10.1056/NEJM199503093321003
Steingrimur Stefansson, Daniel A. Lawrence, The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. ,vol. 383, pp. 441- 443 ,(1996) , 10.1038/383441A0
A. Hamsten, P. Eriksson, B. Kallin, F. M. van 't Hooft, P. Bavenholm, Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 1851- 1855 ,(1995) , 10.1073/PNAS.92.6.1851